These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes. Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814 [TBL] [Abstract][Full Text] [Related]
8. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes. Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603 [TBL] [Abstract][Full Text] [Related]
9. Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. Monie A; Hung CF; Roden R; Wu TC Biologics; 2008 Mar; 2(1):97-105. PubMed ID: 19707432 [TBL] [Abstract][Full Text] [Related]
10. A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses. Seitz H; Canali E; Ribeiro-Müller L; Pàlfi A; Bolchi A; Tommasino M; Ottonello S; Müller M Vaccine; 2014 May; 32(22):2610-7. PubMed ID: 24662712 [TBL] [Abstract][Full Text] [Related]
11. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach. Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA Virol J; 2015 Sep; 12():140. PubMed ID: 26362430 [TBL] [Abstract][Full Text] [Related]
12. A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls. Draper E; Bissett SL; Howell-Jones R; Waight P; Soldan K; Jit M; Andrews N; Miller E; Beddows S PLoS One; 2013; 8(5):e61825. PubMed ID: 23650505 [TBL] [Abstract][Full Text] [Related]
13. Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine. Godi A; Bissett SL; Miller E; Beddows S PLoS One; 2015; 10(10):e0140926. PubMed ID: 26495976 [TBL] [Abstract][Full Text] [Related]
14. Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP. Valencia SM; Zacharia A; Marin A; Matthews RL; Wu CK; Myers B; Sanders C; Difilippantonio S; Kirnbauer R; Roden RB; Pinto LA; Shoemaker RH; Andrianov AK; Marshall JD Hum Vaccin Immunother; 2021 Aug; 17(8):2748-2761. PubMed ID: 33573433 [TBL] [Abstract][Full Text] [Related]
15. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses. Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932 [TBL] [Abstract][Full Text] [Related]
16. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today? Yadav R; Zhai L; Tumban E Viruses; 2019 Dec; 12(1):. PubMed ID: 31877975 [TBL] [Abstract][Full Text] [Related]
17. A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9. Zhai L; Peabody J; Pang YS; Schiller J; Chackerian B; Tumban E Antiviral Res; 2017 Nov; 147():116-123. PubMed ID: 28939477 [TBL] [Abstract][Full Text] [Related]
19. Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing. Tyler M; Tumban E; Dziduszko A; Ozbun MA; Peabody DS; Chackerian B Vaccine; 2014 Jul; 32(34):4267-74. PubMed ID: 24962748 [TBL] [Abstract][Full Text] [Related]
20. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]